On October 7, 2026, Picard Medical, Inc. filed a Current Report on Form 8-K announcing that its Board of Directors approved an amendment to the company's Amended and Restated Bylaws. The amendment, which became effective immediately upon approval, specifically targets Section 9 of the governing document.
The primary change involves the reduction of the quorum requirement for meetings of the company's stockholders. Previously, a majority of the voting power of the company’s issued and outstanding shares was necessary to constitute a quorum. Under the new amendment, this threshold has been lowered to thirty-three and one-third percent (33 1/3%) of the voting power of such shares.
The company stated that this modification is intended to comply with the minimum quorum requirements set forth in Section 216 of the Delaware General Corporation Law and Section 123 of the NYSE American Company Guide. A copy of the full text of the amendment is filed as Exhibit 3.1 to the report.
